vs
Side-by-side financial comparison of NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
NORTHERN TECHNOLOGIES INTERNATIONAL CORP is the larger business by last-quarter revenue ($23.3M vs $18.3M, roughly 1.3× ROCKWELL MEDICAL, INC.). NORTHERN TECHNOLOGIES INTERNATIONAL CORP runs the higher net margin — 1.0% vs -3.0%, a 4.0% gap on every dollar of revenue. On growth, NORTHERN TECHNOLOGIES INTERNATIONAL CORP posted the faster year-over-year revenue change (9.2% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-479.7K). Over the past eight quarters, NORTHERN TECHNOLOGIES INTERNATIONAL CORP's revenue compounded faster (5.8% CAGR vs -10.1%).
Maxar Technologies Inc., was an American space technology company, specializing in geospatial intelligence, Earth observation, and on-orbit satellite servicing, satellite products, and related services. DigitalGlobe and MDA Holdings Company merged to become Maxar Technologies on October 5, 2017.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NTIC vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.3M | $18.3M |
| Net Profit | $237.8K | $-554.0K |
| Gross Margin | 36.0% | 21.1% |
| Operating Margin | 4.0% | -2.2% |
| Net Margin | 1.0% | -3.0% |
| Revenue YoY | 9.2% | -25.6% |
| Net Profit YoY | -57.6% | 26.7% |
| EPS (diluted) | $0.03 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.3M | $18.3M | ||
| Q3 25 | $22.3M | $15.9M | ||
| Q2 25 | $21.5M | $16.1M | ||
| Q1 25 | $19.1M | $18.9M | ||
| Q4 24 | $21.3M | $24.7M | ||
| Q3 24 | $23.3M | $28.3M | ||
| Q2 24 | $20.7M | $25.8M | ||
| Q1 24 | $20.8M | $22.7M |
| Q4 25 | $237.8K | $-554.0K | ||
| Q3 25 | $-1.1M | $-1.8M | ||
| Q2 25 | $121.8K | $-1.5M | ||
| Q1 25 | $434.3K | $-1.5M | ||
| Q4 24 | $561.1K | $-756.0K | ||
| Q3 24 | $1.8M | $1.7M | ||
| Q2 24 | $976.6K | $343.0K | ||
| Q1 24 | $1.7M | $-1.7M |
| Q4 25 | 36.0% | 21.1% | ||
| Q3 25 | 37.9% | 14.3% | ||
| Q2 25 | 38.4% | 15.6% | ||
| Q1 25 | 35.6% | 16.1% | ||
| Q4 24 | 38.3% | 14.7% | ||
| Q3 24 | 43.8% | 22.0% | ||
| Q2 24 | 38.2% | 17.6% | ||
| Q1 24 | 40.0% | 13.5% |
| Q4 25 | 4.0% | -2.2% | ||
| Q3 25 | 4.2% | -9.9% | ||
| Q2 25 | 4.0% | -8.4% | ||
| Q1 25 | -1.7% | -7.2% | ||
| Q4 24 | 5.2% | -2.1% | ||
| Q3 24 | 11.8% | 6.8% | ||
| Q2 24 | 7.4% | 2.0% | ||
| Q1 24 | 10.6% | -5.8% |
| Q4 25 | 1.0% | -3.0% | ||
| Q3 25 | -4.9% | -11.0% | ||
| Q2 25 | 0.6% | -9.3% | ||
| Q1 25 | 2.3% | -8.0% | ||
| Q4 24 | 2.6% | -3.1% | ||
| Q3 24 | 7.9% | 5.9% | ||
| Q2 24 | 4.7% | 1.3% | ||
| Q1 24 | 8.2% | -7.6% |
| Q4 25 | $0.03 | $-0.01 | ||
| Q3 25 | $-0.11 | $-0.05 | ||
| Q2 25 | $0.01 | $-0.05 | ||
| Q1 25 | $0.04 | $-0.04 | ||
| Q4 24 | $0.06 | $-0.02 | ||
| Q3 24 | $0.19 | $0.04 | ||
| Q2 24 | $0.10 | $0.01 | ||
| Q1 24 | $0.17 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $72.4M | $37.0M |
| Total Assets | $104.0M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $10.7M | ||
| Q3 25 | $7.3M | $13.6M | ||
| Q2 25 | $6.8M | $12.5M | ||
| Q1 25 | $5.1M | $11.4M | ||
| Q4 24 | $5.6M | $15.7M | ||
| Q3 24 | $5.0M | $12.3M | ||
| Q2 24 | $5.8M | $11.9M | ||
| Q1 24 | $4.8M | $6.6M |
| Q4 25 | $72.4M | $37.0M | ||
| Q3 25 | $72.1M | $37.0M | ||
| Q2 25 | $72.4M | $30.4M | ||
| Q1 25 | $69.7M | $31.5M | ||
| Q4 24 | $70.2M | $32.6M | ||
| Q3 24 | $71.2M | $29.1M | ||
| Q2 24 | $68.9M | $23.5M | ||
| Q1 24 | $68.4M | $20.6M |
| Q4 25 | $104.0M | $57.1M | ||
| Q3 25 | $102.7M | $57.5M | ||
| Q2 25 | $99.3M | $52.6M | ||
| Q1 25 | $93.7M | $54.0M | ||
| Q4 24 | $94.0M | $59.2M | ||
| Q3 24 | $94.7M | $57.1M | ||
| Q2 24 | $89.3M | $53.0M | ||
| Q1 24 | $87.3M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.9K | $2.3M |
| Free Cash FlowOCF − Capex | $-479.7K | $2.2M |
| FCF MarginFCF / Revenue | -2.1% | 12.0% |
| Capex IntensityCapex / Revenue | 3.5% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.8M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.9K | $2.3M | ||
| Q3 25 | $-1.4M | $-1.3M | ||
| Q2 25 | $609.7K | $1.8M | ||
| Q1 25 | $803.7K | $-3.5M | ||
| Q4 24 | $2.4M | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | $1.9M | $1.4M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | $-479.7K | $2.2M | ||
| Q3 25 | $-1.4M | $-1.5M | ||
| Q2 25 | $-171.2K | $1.7M | ||
| Q1 25 | $293.1K | $-3.5M | ||
| Q4 24 | $1.2M | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | $869.4K | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | -2.1% | 12.0% | ||
| Q3 25 | -6.3% | -9.6% | ||
| Q2 25 | -0.8% | 10.5% | ||
| Q1 25 | 1.5% | -18.8% | ||
| Q4 24 | 5.5% | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | 4.2% | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | 3.5% | 0.5% | ||
| Q3 25 | 0.2% | 1.4% | ||
| Q2 25 | 3.6% | 1.0% | ||
| Q1 25 | 2.7% | 0.3% | ||
| Q4 24 | 5.7% | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | 5.2% | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 1.44× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 1.85× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 1.99× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTIC
| Inside The USA To Unaffiliated Customers | $7.5M | 32% |
| Natur Tec | $6.0M | 26% |
| Acobal | $3.6M | 15% |
| Other | $2.7M | 12% |
| BR | $2.1M | 9% |
| Zerust OY | $1.4M | 6% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
